ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants

April 30, 1982

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003